These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11438319

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
    Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S, Jacobs H.
    Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
    [Abstract] [Full Text] [Related]

  • 27. Levels of circulating intercellular adhesion molecule 1 and E-selectin in serum and synovial fluid of juvenile chronic arthritis patients.
    Bardare M, Corona F, Di Francesco L, Memeo A, Cimaz R, Cohen E.
    Acta Univ Carol Med (Praha); 1994 Oct; 40(1-4):81-5. PubMed ID: 9355678
    [Abstract] [Full Text] [Related]

  • 28. Serum albumin levels in women with ovarian hyperstimulation syndrome with or without polycystic ovaries.
    Alserri A, Holzer H, Tulandi T.
    J Obstet Gynaecol Can; 2012 Sep; 34(9):866-869. PubMed ID: 22971456
    [Abstract] [Full Text] [Related]

  • 29. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
    Choux C, Barberet J, Ginod P, Cottenet J, Bruno C, Benzénine E, Sagot P, Fauque P.
    Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, García-Velasco JA, Simón C, Pellicer A.
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
    Mathur R, Hayman G, Bansal A, Jenkins J.
    Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
    [Abstract] [Full Text] [Related]

  • 35. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER.
    Fertil Steril; 2010 Mar 01; 93(4):1215-9. PubMed ID: 19200978
    [Abstract] [Full Text] [Related]

  • 36. Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA, Mansour RT, Serour GI, Elhelw BA, Shaarawy M.
    Hum Reprod; 1998 Aug 01; 13(8):2068-71. PubMed ID: 9756270
    [Abstract] [Full Text] [Related]

  • 37. Unsuspected adverse effect of albumin in severe ovarian hyperstimulation syndrome: a case report.
    Darii N, Pavlovic M, Doroftei B, Emil A.
    JBRA Assist Reprod; 2019 Oct 14; 23(4):430-433. PubMed ID: 31058477
    [Abstract] [Full Text] [Related]

  • 38. Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer.
    Ferdeghini M, Gadducci A, Prontera C, Annicchiarico C, Gagetti O, Bianchi M, Facchini V, Genazzani AR.
    Anticancer Res; 1995 Oct 14; 15(5B):2255-60. PubMed ID: 8572633
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.